The Technical Analyst
Select Language :
Zosano Pharma Corp [ZSAN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Zosano Pharma Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Zosano Pharma Corp is listed at the  Exchange

0.00% $0.558

America/New_York / 31 des 1970 @ 19:00


Zosano Pharma Corp: Main Fundamentals PE comparison

RATING 2022-08-05
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Buy
P/E: Neutral
Price To Book: Neutral
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.936 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.33x
Company: PE -1.936 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.337 - 0.779

( +/- 39.63%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-06-06 Matthews Christine Sell 82 Common Stock
2022-06-06 Lo Steven Sell 442 Common Stock
2022-03-31 Matthews Christine Sell 8 116 Common Stock
2022-03-31 Kellerman Donald J Sell 4 006 Common Stock
2022-03-31 Lo Steven Sell 23 633 Common Stock
INSIDER POWER
-100.00
Last 98 transactions
Buy: 6 809 170 | Sell: 191 091

Forecast: 01:40 - $1.864

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.558 (0.00% )
Volume 1.155 mill
Avg. Vol. 5.36 mill
% of Avg. Vol 21.54 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Zosano Pharma Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Zosano Pharma Corp

RSI

Intraday RSI14 chart for Zosano Pharma Corp

Last 10 Buy & Sell Signals For ZSAN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Zosano Pharma Corp

ZSAN

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Last 10 Buy Signals

Date Signal @
USDDUSDMar 28 - 14:400.996
WNXMUSDMar 28 - 14:3973.64
ORDIUSDMar 28 - 14:3962.22
MOVRUSDMar 28 - 14:40$21.53
KNCUSDMar 28 - 14:39$0.906
AVTUSDMar 28 - 14:395.95
NEOUSDMar 28 - 14:38$15.95
AZNMar 28 - 14:38$67.90
ZIONMar 28 - 14:37$43.13
KSMUSDMar 28 - 14:37$48.61

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.